ArticleCancers2024

The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide.

So Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.